ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,070Medicare Part D Prescriptions Filled, Including Refills

Rank: 323 out of 1107

$593K Total Retail Price of All Prescriptions

Rank: 294 out of 1107

185 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 185 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

35% of this provider’s 185 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

0% of this provider’s 7,744 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

54 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
AMLODIPINE BESYLATE 436 377 1 6
LOVASTATIN 319 261 2 55
HYDROCODONE-ACETAMINOPHEN 284 199 S3 3 1
CARVEDILOL 273 250 4 27
PRAVASTATIN SODIUM 266 224 5 12
FAMOTIDINE 247 176 6 111
METFORMIN HCL ER 246 152 7 58
OMEPRAZOLE 235 145 8 4
GABAPENTIN 231 129 9 9
BENAZEPRIL HCL 222 192 10 86
NIASPAN 217 162 11 125
SYNTHROID 213 201 12 70
BISOPROLOL FUMARATE 203 163 13 136
LEVOTHYROXINE SODIUM 201 157 14 3
TORSEMIDE 197 151 15 177
LISINOPRIL 195 147 16 2
WARFARIN SODIUM 156 143 17 15
LOVAZA 148 74 18 101
MIRTAZAPINE 147 130 19 61
METOPROLOL SUCCINATE 144 142 20 16
LOSARTAN POTASSIUM 137 120 21 29
CITALOPRAM HBR 122 93 22 17
ATORVASTATIN CALCIUM 117 81 23 13
ACETAMINOPHEN-CODEINE 114 108 S3 24 120
SERTRALINE HCL 105 59 25 20
ISOSORBIDE MONONITRATE ER 94 90 26 34
CLONIDINE HCL 88 70 27 53
NAMENDA 84 84 28 42
FLUTICASONE PROPIONATE 82 46 29 38
SPIRIVA 76 55 30 57
CYMBALTA 74 31 31 50
NEXIUM 73 48 32 18
DONEPEZIL HCL 71 71 33 32
CARBIDOPA-LEVODOPA 69 69 34 122
DILTIAZEM 24HR CD 68 48 35 126
PROAIR HFA 67 57 36 37
BUPROPION HCL SR 65 37 37 190
CRESTOR 64 40 38 23
METOPROLOL TARTRATE 63 44 39 10
ROPINIROLE HCL 62 39 40 69
DIOVAN 61 46 41 51
AZITHROMYCIN 61 36 41 35
CHLORTHALIDONE 57 51 43 175
ENOXAPARIN SODIUM 56 56 44 285
DIGOXIN 55 43 45 52
ISRADIPINE 54 51 10 46 454
FENOFIBRATE 54 12 46 67
MELOXICAM 51 26 48 25
IMIPRAMINE HCL 50 28 R 49 389
MORPHINE SULFATE 50 44 S2 49 308
SIMVASTATIN 50 37 49 5
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.